Janson C H, Grunewald J, Osterborg A, DerSimonian H, Brenner M B, Mellstedt H, Wigzell H
Department of Immunology, Karolinska Institute, Stockholm, Sweden.
Blood. 1991 Apr 15;77(8):1776-80.
We have examined alpha/beta V gene segment usage of peripheral blood CD4+ and CD8+ T cells, respectively, from patients with multiple myeloma and monoclonal gammopathy of undetermined significance, by using T cell receptor (TCR) for antigen monoclonal antibodies (MoAbs). In 7 of 16 patients we found an increase in the usage of various TCR V gene segments. The expansion was confined to either the CD4+ or the CD8+ T-cell subset, except for one patient where an abnormal pattern was observed both within the CD4+ and CD8+ T-cell subsets. In one patient 47%, and in another patient 30% of the CD8+ lymphocytes reacted with alpha V12.1 and beta V6.7 antibodies, respectively. In two other patients 29% and 40% of the CD4+ lymphocytes reacted with beta V6.7 and beta V8.1 antibodies, respectively. We conclude that T cells with a predominant V gene usage is a frequent feature in patients with abnormal clonal B cells of malignant or benign types. T- and B-cell populations are normally clonally linked in regulatory circuits. An abnormal proliferation of B cells might therefore induce, or be regulated by, an expansion of clonal T cells, as suggested by the present results.
我们使用针对抗原的单克隆抗体(MoAbs)的T细胞受体(TCR),分别检测了多发性骨髓瘤患者和意义未明的单克隆丙种球蛋白病患者外周血CD4 +和CD8 + T细胞的α/βV基因片段使用情况。在16例患者中的7例中,我们发现各种TCR V基因片段的使用增加。这种扩增局限于CD4 +或CD8 + T细胞亚群,只有1例患者在CD4 +和CD8 + T细胞亚群中均观察到异常模式。在1例患者中,47%的CD8 +淋巴细胞分别与αV12.1和βV6.7抗体发生反应;在另1例患者中,30%的CD8 +淋巴细胞分别与αV12.1和βV6.7抗体发生反应。在另外2例患者中,29%和40%的CD4 +淋巴细胞分别与βV6.7和βV8.1抗体发生反应。我们得出结论,具有主要V基因使用情况的T细胞是恶性或良性类型异常克隆B细胞患者的常见特征。T细胞和B细胞群体在调节回路中通常是克隆相关的。因此,正如本研究结果所示,B细胞的异常增殖可能会诱导克隆性T细胞的扩增,或者受其调节。